Saturday, August 1, 2026

Super Micro Posts 9% Gain, Riding NVIDIA’s Rebound After A Dramatic Decline

Super Micro's stock surged 9% after NVIDIA's rebound, reflecting renewed investor confidence following a tumultuous year of setbacks.

Another North Korean Defects to the South

Early this morning, a North Korean soldier defected to South Korea near the Army's 22nd Division in Goseong County, Gangwon Province.

Google’s Quantum Leap: How the ‘Willow’ Chip Reduces Errors in Quantum Computing

Google advances quantum computing with its Willow chip, reducing errors and demonstrating OTOC measurements, enhancing commercial viability.

Tag: Lazertinib

Yuhan to Receive $30 Million Milestone From European Launch of Lazertinib Combination Therapy

Yuhan Corporation receives a $30M milestone for Lazertinib's European launch, totaling $300M in payments, aiming for global healthcare leadership.

Yuhan’s Leclaza and J&J’s Rybrevant: How This Cancer Combo Surged Past 1 Billion USD in Sales

Sales of Yuhan's lung cancer drug 'Lazertinib' and J&J's 'Amivantamab' exceeded 1 trillion won last year.

Top News

- Our Sponsors Ad -

Follow us